Skinly Aesthetics（New York, NY）

Skinly Aesthetics operates as a dual-focus medical practice in New York, NY, combining peptide-based metabolic therapies with cosmetic dermatology under the direction of Dr. Dmitriy Schwarzburg, a board-certified physician with Ivy League medical training. The clinic addresses both functional wellness concerns—particularly weight management and hormonal balance—and aesthetic goals through injectable treatments, creating a comprehensive approach for patients seeking improvements in body composition, energy regulation, and facial rejuvenation within a single practice setting.

The peptide therapy program centers on GLP-1 receptor agonists semaglutide and tirzepatide for medically supervised weight loss, prescribed following metabolic assessment and tailored to individual response patterns and weight reduction targets. NAD+ infusion therapy supports cellular energy production and is incorporated into protocols for patients addressing fatigue, cognitive clarity, and age-related metabolic decline. Hormone optimization services evaluate thyroid function, sex hormone levels, and adrenal status, with peptide interventions selected based on laboratory findings and symptom profiles. These metabolic treatments operate alongside the clinic’s aesthetic services, which include neuromodulator injections for forehead lines and masseter reduction, dermal fillers for volume restoration, and biostimulatory agents like Sculptra for collagen induction, allowing patients to address both internal health markers and external appearance concerns.

Dr. Schwarzburg brings formal medical training from an Ivy League institution and board certification to his dual practice model, applying clinical rigor to both peptide prescribing and aesthetic injection techniques. His approach involves detailed consultation to establish realistic timelines for weight loss outcomes, review potential side effects of GLP-1 therapies including nausea and injection site reactions, and coordinate peptide treatment with any existing medications or health conditions. For aesthetic procedures, he performs anatomical marking and discusses expected recovery periods, bruising likelihood, and product longevity. The clinic’s model allows patients to consolidate multiple treatment goals—such as losing 20-30 pounds via tirzepatide while simultaneously addressing facial volume loss with filler—under one provider’s oversight, reducing the need to coordinate care across separate practices.

Patients visiting the New York office encounter a reception team that manages scheduling for both telehealth peptide consultations and in-person injection appointments, with front desk staff coordinating follow-up visits for weight checks, hormone lab reviews, and aesthetic touch-up sessions. The clinic environment accommodates both brief neuromodulator appointments and longer metabolic consultations, with treatment rooms equipped for IV NAD+ administration and private spaces for body composition discussions. Patients report variability in wait times and front desk responsiveness, factors common in high-volume urban practices, though clinical outcomes for both weight reduction and aesthetic results receive consistent mention in feedback. Post-treatment protocols include specific instructions for managing injection site care, dietary guidelines during GLP-1 therapy, and timelines for assessing filler or Sculptra results, with patients advised on when to schedule follow-up assessments.

Skinly Aesthetics provides telehealth access for initial peptide therapy consultations and ongoing weight loss monitoring, allowing New York-area patients to initiate semaglutide or tirzepatide programs remotely with medication shipped to their homes, while reserving in-person visits for physical examinations, body composition measurements, and all injectable aesthetic procedures. This hybrid model serves patients with demanding schedules who can manage peptide self-injection at home but prefer in-office settings for facial treatments requiring anatomical precision. The practice’s location in New York positions it within a competitive aesthetic market, differentiating itself through the integration of metabolic peptide therapies with cosmetic services rather than operating as a standalone medical spa or weight loss clinic, appealing to patients seeking a medicalized approach to both wellness optimization and appearance enhancement.